Cargando…

Serum Leucine-Rich α2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis

To investigate whether serum leucine-rich α2-glycoprotein (LRG) levels are useful as a marker of disease activity in systemic juvenile idiopathic arthritis (s-JIA), we determined serum LRG levels in fifty-nine s-JIA patients, 15 with other subtypes of JIA, 7 with Kawasaki disease (KD), 7 with influe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Masaki, Inoue, Natsumi, Mizuta, Mao, Nakagishi, Yasuo, Yachie, Akihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378769/ https://www.ncbi.nlm.nih.gov/pubmed/30863782 http://dx.doi.org/10.1155/2019/3140204

Ejemplares similares

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Shimizu, Masaki, et al.
Publicado: (2020)

Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus
por: Nakajima, Madoka, et al.
Publicado: (2011)

Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
por: Irabu, Hitoshi, et al.
Publicado: (2020)

Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)
por: Yasumura, Junko, et al.
Publicado: (2019)

Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
por: Inoue, Natsumi, et al.
Publicado: (2023)

Serum leucine‐rich α2‐glycoprotein as a possible marker for inflammatory status in endometriosis
por: Kobayashi, Mio, et al.
Publicado: (2023)

Up-regulation of the expression of leucine-rich α(2)-glycoprotein in hepatocytes by the mediators of acute-phase response
por: Shirai, Ryoichi, et al.
Publicado: (2009)

Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic Escherichia coli induced hemolytic uremic syndrome
por: Tasaki, Yuko, et al.
Publicado: (2021)

Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis
por: Druhan, Lawrence J., et al.
Publicado: (2017)

Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis
por: Yang, Yi, et al.
Publicado: (2020)

The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury
por: Ma, Hong, et al.
Publicado: (2021)

Diagnostic Utility of Serum Leucine-Rich α-2-Glycoprotein 1 for Acute Appendicitis in Children
por: Tintor, Goran, et al.
Publicado: (2023)

Overexpression of leucine‐rich α2‐glycoprotein‐1 is a prognostic marker and enhances tumor migration in gastric cancer
por: Yamamoto, Masaaki, et al.
Publicado: (2017)

Leucine‐rich α‐2 glycoprotein promotes lung fibrosis by modulating TGF‐β signaling in fibroblasts
por: Honda, Hiromi, et al.
Publicado: (2017)

Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2023)

Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Disease Activity Biomarker in Patients with Rheumatoid Arthritis
por: Ha, You Jung, et al.
Publicado: (2014)

Juvenile idiopathic arthritis
por: Bhatt, Krupa H, et al.
Publicado: (2014)

Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

Serum Leucine-Rich α2 Glycoprotein: A Biomarker for Predicting the Presence of Ulcerative Colitis but Not Ulcerative Proctitis
por: Horiuchi, Ichitaro, et al.
Publicado: (2022)

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
por: Hara, Ryoki, et al.
Publicado: (2019)

Platelet Glycoprotein Ib α‐Chain as a Putative Therapeutic Target for Juvenile Idiopathic Arthritis: A Mendelian Randomization Study
por: Luo, Shan, et al.
Publicado: (2021)

Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
por: Yasutomi, Eriko, et al.
Publicado: (2021)

Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection
por: Kajimoto, Etsuko, et al.
Publicado: (2020)

Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review
por: Zou, Yonghui, et al.
Publicado: (2022)

Leucine-Rich Alpha-2-Glycoprotein: A Novel Predictor of Diastolic Dysfunction
por: Loch, Alexander, et al.
Publicado: (2023)

Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal Disease
por: Yang, Feng-Jung, et al.
Publicado: (2020)

Diagnostic Accuracy of Leucine-Rich α-2-Glycoprotein 1 as a Non-Invasive Salivary Biomarker in Pediatric Appendicitis
por: Tintor, Goran, et al.
Publicado: (2023)

Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease
por: Ichimiya, Tadashi, et al.
Publicado: (2023)

Atherosclerosis in Juvenile Idiopathic Arthritis
por: Jednacz, Ewa, et al.
Publicado: (2012)

Juvenile idiopathic arthritis classification
por: Martini, Alberto
Publicado: (2014)

Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)

The joints in juvenile idiopathic arthritis
por: Ording Muller, Lil-Sofie, et al.
Publicado: (2015)

Ultrasound in juvenile idiopathic arthritis
por: Magni-Manzoni, Silvia
Publicado: (2016)

Haptoglobin in Juvenile Idiopathic Arthritis
por: Berntson, Lillemor, et al.
Publicado: (2022)

Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?
por: Prahalad, Sampath, et al.
Publicado: (2002)

Leucine-Rich α-2-Glycoprotein 1 Suppresses Endothelial Cell Activation Through ADAM10-Mediated Shedding of TNF-α Receptor
por: Pang, Kuin Tian, et al.
Publicado: (2021)

Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma
por: Honda, Hiromi, et al.
Publicado: (2016)

Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis
por: Fujimoto, Minoru, et al.
Publicado: (2020)

Leucine-rich alpha-2-glycoprotein 1 and angiotensinogen as diagnostic biomarkers for Kawasaki disease
por: Yanagimachi, Masakatsu, et al.
Publicado: (2021)

Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides
por: Umezawa, Natsuka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_482m04trtmqntnheb87piq0sa2